Clinical Trial Update: Middle Meningeal Artery Embolization for Chronic Migraine [NA]

View source ↗

Summary

The clinical trial NCT07044648 evaluating middle meningeal artery embolization for chronic migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Migraine | NA | Status: WITHDRAWN